Prime Medicine Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.52

-0.16 (-4.35%)

As of Mar 22, 10:18 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 12 71%

Hold 5 29%

Sell 0 0%

Price Target

Analyst Price Target +1,127.0% upside

Low Target $33.60

Average Target $43.19

High Target $71.66

Current Price $3.52

Current
$3.52

Target
$43.19

$33.60 $43.19 avg $71.66

Scenario Analysis

Bear Case

$33.60

854.5%

Low target

Base Case

$43.19

+1,127.0%

Avg target

Bull Case

$71.66

+1,935.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$6.94

-49.3% from high

52-Week Low

$1.11

+217.1% from low

Target vs 52W High

$43.19

+522.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%